A Day Up For Apellis Pharmaceuticals, Inc.
Wed, Aug 23, 2023 at 07:04 PM
Apellis Pharmaceuticals, Inc. (APLS:NASDAQ) rocketted at $40.04, a gain of 30.2%. On Wed, Aug 23, 2023, APLS:NASDAQ touched a New 2-Week High of $40.04. The stock got featured on our News Catalysts scanner on Wed, Aug 23, 2023 at 06:03 PM in the 'MISCELLANEOUS' category. From Wed, Aug 09, 2023, the stock recorded 50.00% Up Days and 63.64% Green Days
About Apellis Pharmaceuticals, Inc. (APLS:NASDAQ)
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.
Top 10 Gainers:
- VCI Global Limited (VCIG:NASDAQ), 84%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 80.83%
- Mullen Automotive Inc. (MULN:NASDAQ), 68.07%
- AgileThought Inc. (AGIL:NASDAQ), 61.18%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 38.33%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 33.72%
- Apellis Pharmaceuticals, Inc. (APLS:NASDAQ), 30.17%
- One Stop Systems, Inc. (OSS:NASDAQ), 29.52%
- Graphex Group Limited American Depositary Shares each American Depositary Share representing 20 (GRFX:NYSEMKT), 29.17%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 28.5%